Colorectal Cancer in Young Adults

Seminars in Oncology

Volumn 36, Issue 5, 2009, Pages 439-450

  Zbuk, Kevin ^a   Sidebotham, Emma L ^b   Bleyer, Archie ^c   La Quaglia, Michael P ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c ST CHARLES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; PANITUMUMAB; VASCULOTROPIN INHIBITOR;

ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CLINICAL FEATURE; CLINICAL TRIAL; COLON CANCER; COLORECTAL CANCER; HUMAN; MEDICAL LITERATURE; METASTASIS; MICROSATELLITE INSTABILITY; MOLECULAR GENETICS; NEUROPATHY; PATHOLOGY; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; REPRODUCTIVE HEALTH; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; HUMANS; INCIDENCE; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; UNITED STATES; YOUNG ADULT;

EID: 70349768049     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2009.07.008     Document Type: Article

References (82)

1. O'Connell J.B., Maggard M.A., Livingston E.H., and Yo C.K. Colorectal cancer in the young. Am J Surg 187 (2004) 343-348
2. O'Connell J.B., Maggard M.A., Liu J.H., Etzioni D.A., Livingston E.H., and Ko C.Y. Rates of colon and rectal cancers are increasing in young adults. Am Surg 69 (2003) 866-872
3. O'Connell J.B., Maggard M.A., Liu J.H., Etzioni D.A., Livingston E.H., and Ko C.Y. Do young colon cancer patients have worse outcomes?. World J Surg 28 (2004) 558-562
4. Griffin P.M., Liff J.M., Greenberg R.S., and Clark W.S. Adenocarcinomas of the colon and rectum in persons under 40 years old. A population-based study. Gastroenterology 100 (1991) 1033-1040
5. Durno C.A., and Gallinger S. Genetic predisposition to colorectal cancer: new pieces in the pediatric puzzle. J Pediatr Gastroenterol Nutr 43 (2006) 5-15
6. Kastrinos F., Stoffel E.M., Balmana J., Steyerberg E.W., Mercado R., and Syngal S. Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States. Cancer Epidemiol Biomarkers Prev 17 (2008) 2044-2051
7. Goecke T., Schulmann K., Engel C., Holinski-Feder E., Pagenstecher C., Schackert H.K., et al. Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol 24 (2006) 4285-4292
8. Evans D.G., Walsh S., Hill J., and McMahon R.T. Strategies for identifying hereditary nonpolyposis colon cancer. Semin Oncol 34 (2007) 411-417
9. Watson P.L.H. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71 (1993) 677-685
10. Vasen H.F., Mecklin J.P., Khan P.M., and Lynch H.T. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34 (1991) 424-425
11. Durno C., Aronson M., Bapat B., Cohen Z., and Gallinger S. Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma. Gut 54 (2005) 1146-1150
12. Umar A., Boland C.R., Terdiman J.P., Syngal S., de la Chapelle A., Ruschoff J., et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96 (2004) 261-268
13. Barnetson R.A., Tenesa A., Farrington S.M., Nicholl I.D., Cetnarskyj R., Porteous M.E., et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 354 (2006) 2751-2763
14. Stigliano V., Assisi D., Cosimelli M., Palmirotta R., Giannarelli D., Mottolese M., et al. Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients. J Exp Clin Cancer Res 27 (2008) 39
15. Dionigi G., Bianchi V., Villa F., Rovera F., Boni L., Annoni M., et al. Differences between familial and sporadic forms of colorectal cancer with DNA microsatellite instability. Surg Oncol 16 Suppl 1 (2007) S37-S42
16. Al-Sukhni W., Aronson M., and Gallinger S. Hereditary colorectal cancer syndromes: familial adenomatous polyposis and lynch syndrome. Surg Clin North Am 88 (2008) 819-844
17. Giardiello F.M., Petersen G.M., Brensinger J.D., Luce M.C., Cayouette M.C., Bacon J., et al. Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut 39 (1996) 867-869
18. LeSher A., Castronuovo J.J., and Fillippone A.L. Hepatoblastoma in a patient with familial polyposis coli. Surgery 105 (1989) 668-670
19. Winawer S., Fletcher R., Rex D., Bond J., Burt R., Ferrucci J., et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 124 (2003) 544-560
20. Leddin D., Hunt R., Champion M., Cockeram A., Flook N., Gould M., et al. Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: guidelines on colon cancer screening. Can J Gastroenterol 18 (2004) 93-99
21. Vogelstein B. Genetic testings for cancer: the surgeon's critical role. Familial colon cancer. J Am Coll Surg 188 (1999) 74-79
22. Caspari R., Friedl W., Mandl M., Moslein G., Kadmon M., Knapp M., et al. Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer. Lancet 343 (1994) 629-632
23. Caspari R., Olschwang S., Friedl W., Mandl M., Boisson C., Boker T., et al. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 4 (1995) 337-340
24. Couture J., Mitri A., Lagace R., Smits R., Berk T., Bouchard H.L., et al. A germline mutation at the extreme 3′ end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor. Clin Genet 57 (2000) 205-212
25. Al-Tassan N., Chmiel N.H., Maynard J., Fleming N., Livingston A.L., Williams G.T., et al. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat Genet 30 (2002) 227-232
26. Enholm S., Hienonen T., Suomalainen A., Lipton L., Tomlinson I., Karja V., et al. Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients. Am J Pathol 163 (2003) 827-832
27. Zbuk K.M., and Eng C. Hamartomatous polyposis syndromes. Nat Clin Pract Gastroenterol Hepatol 4 (2007) 492-502
28. Hill D.A., Furman W.L., Billups C.A., Riedley S.E., Cain A.M., Rao B.N., et al. Colorectal carcinoma in childhood and adolescence: a clinicopathologic review. J Clin Oncol 25 (2007) 5808-5814
29. American Academy of Pediatrics Section on Hematology/Oncology Children's Oncology Group. Long-term follow-up care for pediatric cancer survivors. Pediatrics 123 (2009) 906-915
30. Canavan C., Abrams K.R., and Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 23 (2006) 1097-1104
31. Eaden J.A., Abrams K.R., and Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48 (2001) 526-535
32. LaQuaglia M.P., Heller G., Filippa D.A., Karasakalides A., Vlamis V., Wollner N., et al. Prognostic factors and outcome in patients 21 years and under with colorectal carcinoma. J Pediatr Surg 27 (1992) 1085-1089
33. Kravarusic D., Feigin E., Dlugy E., Steinberg R., Baazov A., Erez I., et al. Colorectal carcinoma in childhood: a retrospective multicenter study. J Pediatr Gastroenterol Nutr 44 (2007) 209-211
34. Sivit C.J. Contemporary imaging in abdominal emergencies. Pediatr Radiol 38 Suppl 4 (2008) S675-S678
35. Stevenson G.W. Radiology and endoscopy in the pretreatment diagnostic management of colorectal cancer. Cancer 71 Suppl (1993) 4198-4206
36. Galia M., Midiri M., Carcione A., Cusma S., Bartolotta T.V., Angileri T., et al. Usefulness of CT colonography in the preoperative evaluation of patients with distal occlusive colorectal carcinoma. Radiol Med 101 (2001) 235-242
37. MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology 243 (2007) 132-139
38. Brown G., Radcliffe A.G., Newcombe R.G., Dallimore N.S., Bourne M.W., and Williams G.T. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 90 (2003) 355-364
39. Vikram R., and Iyer R.B. PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer. Cancer Imaging 8 Suppl A (2008) S46-S51
40. Engstrom P.F., Benson III A.B., Chen Y.J., Choti M.A., Dilawari R.A., Enke C.A., et al. Colon cancer clinical practice guidelines in oncology. J Natl Compr Cancer Netw 3 (2005) 468-491
41. In: Greene F.L., Page D.L., Fleming I.D., Fritz A., Balch C.M., Haller D.G., et al. (Eds). AJCC cancer staging manual. 6th ed. (2002), Springer Verlag, Berlin
42. Astler V.B., and Coller F.A. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139 (1954) 846-852
43. Bleyer A., Barr R., Hayes-Lattin B., Thomas D., Ellis C., and Anderson B. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer 8 (2008) 288-298
44. Rajagopalan H., Nowak M.A., Vogelstein B., and Lengauer C. The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer 3 (2003) 695-701
45. Popat S., Hubner R., and Houlston R.S. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23 (2005) 609-618
46. Quah H.M., Joseph R., Schrag D., Shia J., Guillem J.G., Paty P.B., et al. Young age influences treatment but not outcome of colon cancer. Ann Surg Oncol 14 (2007) 2759-2765
47. Benson III A.B., Schrag D., Somerfield M.R., Cohen A.M., Figueredo A.T., Flynn P.J., et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22 (2004) 3408-3419
48. Figueredo A., Charette M.L., Maroun J., Brouwers M.C., and Zuraw L. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. J Clin Oncol 22 (2004) 3395-3407
49. Gray R., Barnwell J., McConkey C., Hills R.K., Williams N.S., et al., Quasar Collaborative Group. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 370 (2007) 2020-2029
50. Ota D., and Nelson H. The surgeon and adjuvant therapy for stage II colon cancer. Ann Surg Oncol 14 (2007) 272-273
51. Andre T., Colin P., Louvet C., Gamelin E., Bouche O., Achille E., et al. Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial. J Clin Oncol 21 (2003) 2896-2903
52. Andre T., Boni C., Mounedji-Boudiaf L., Navarro M., Tabernero J., Hickish T., et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350 (2004) 2343-2351
53. Harmon K.E., Ryan Jr. J.A., Biehl T.R., and Lee F.T. Benefits and safety of hepatic resection for colorectal metastases. Am J Surg 177 (1999) 402-404
54. Tournigand C., Andre T., Achille E., Lledo G., Flesh M., Mery-Mignard D., et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22 (2004) 229-237
55. Cunningham D., Humblet Y., Siena S., Khayat D., Bleiberg H., Santoro A., et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351 (2004) 337-345
56. Freyer G., Rougier P., Bugat R., Droz J.P., Marty M., Bleiberg H., et al. Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups. Br J Cancer 83 (2000) 431-437
57. Simmonds P.C. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ 321 (2000) 531-535
58. Peeters M., Balfour J., and Arnold D. Review article: panitumumab-a fully human anti-EGFR monoclonal antibody for treatment of metastatic colorectal cancer. Aliment Pharmacol Ther 28 (2008) 269-281
59. Yan L., Hsu K., and Beckman R.A. Antibody-based therapy for solid tumors. Cancer J 14 (2008) 178-183
60. Siena S., Peeters M., Van Cutsem E., Humblet Y., Conte P., Bajetta E., et al. Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab. Br J Cancer 97 (2007) 1469-1474
61. Jonker D.J., O'Callaghan C.J., Karapetis C.S., Zalcberg J.R., Tu D., Au H.J., et al. Cetuximab for the treatment of colorectal cancer. N Engl J Med 357 (2007) 2040-2048
62. Hurwitz H., Fehrenbacher L., Novotny W., Cartwright T., Hainsworth J., Heim W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350 (2004) 2335-2342
63. Seegenschmiedt M.H., Martus P., Goldmann A.R., Wolfel R., Keilholz L., and Sauer R. Preoperative versus postoperative radiotherapy for prevention of heterotopic ossification (HO): first results of a randomized trial in high-risk patients. Int J Radiat Oncol Biol Phys 30 (1994) 63-73
64. Engstrom P. Update: NCCN colon cancer clinical practice guidelines. J Natl Compr Cancer Netw 3 Suppl 1 (2005) S25-S28
65. Kumar A., Ansari M., Shukla D., Tripathi A.K., and Shyam R. Augmentation gastroplasty using a segment of transverse colon for corrosive gastric stricture. Int J Colorectal Dis 21 (2006) 470-472
66. Tohme C., Labaki M., Hajj G., Abboud B., Noun R., and Sarkis R. Colorectal cancer in young patients: presentation, clinicopathological characteristics and outcome. J Med Liban 56 (2008) 208-214
67. O'Connell J.B., Maggard M.A., Liu J.H., Etzioni D.A., and Ko C.Y. Are survival rates different for young and older patients with rectal cancer?. Dis Colon Rectum 47 (2004) 2064-2069
68. Datta R.V., LaQuaglia M.P., and Paty P.B. Genetic and phenotypic correlates of colorectal cancer in young patients. N Engl J Med 342 (2000) 137-138
69. Gryfe R., Kim H., Hsieh E.T., Aronson M.D., Holowaty E.J., Bull S.B., et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342 (2000) 69-77
70. Muller C.I., Schulmann K., Reinacher-Schick A., Andre N., Arnold D., Tannapfel A., et al. Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group. Int J Colorectal Dis 23 (2008) 1033-1039
71. des Guetz G., Mariani P., Cucherousset J., Benamoun M., Lagorce C., Sastre X., et al. Microsatellite instability and sensitivitiy to FOLFOX treatment in metastatic colorectal cancer. Anticancer Res 27 (2007) 2715-2719
72. Fallik D., Borrini F., Boige V., Viguier J., Jacob S., Miquel C., et al. Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer. Cancer Res 63 (2003) 5738-5744
73. Spanos C.P., Mamopoulos A., Tsapas A., Syrakos T., and Kiskinis D. Female fertility and colorectal cancer. Int J Colorectal Dis 23 (2008) 735-743
74. Marhhom E., and Cohen I. Fertility preservation options for women with malignancies. Obstet Gynecol Surv 62 (2007) 58-72
75. Strong M., Peche W., and Scaife C. Incidence of fertility counseling of women of child-bearing age before treatment for colorectal cancer. Am J Surg 194 (2007) 765-767
76. Olsen K.O., Joelsson M., Laurberg S., and Oresland T. Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis. Br J Surg 86 (1999) 493-495
77. Wallace W.H., Thomson A.B., and Kelsey T.W. The radiosensitivity of the human oocyte. Hum Reprod 18 (2003) 117-121
78. Lee S.J., Schover L.R., Partridge A.H., Patrizio P., Wallace W.H., Hagerty K., et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24 (2006) 2917-2931
79. Saif M.W. Management of colorectal cancer in pregnancy: a multimodality approach. Clin Colorectal Cancer 5 (2005) 247-256
80. Cappell M.S. Colon cancer during pregnancy. Gastroenterol Clin North Am 32 (2003) 341-383
81. Gensheimer M., Jones C.A., Graves C.R., Merchant N.B., and Lockhart A.C. Administration of oxaliplatin to a pregnant woman with rectal cancer. Cancer Chemother Pharmacol 63 (2009) 371-373
82. Kanate A.S., Auber M.L., and Higa G.M. Priorities and uncertainties of administering chemotherapy in a pregnant woman with newly diagnosed colorectal cancer. J Oncol Pharm Pract 15 (2009) 5-8